Edwards Lifesciences Corp filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-28. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
The Board of Directors of Edwards Lifesciences Corporation, a Delaware corporation ("Edwards" or the "Company"), has received notice from Donald E. Bobo, Jr., Corporate Vice President, Strategy and Corporate Development, of his decision to retire from the Company by mid-year 2027.
Appointed: Theodora Mistras, Chief Financial Officer, effective 2026-05-29
On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the "Company"), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B. Ullem in that position.
Find people with the same kind of experience as the Chief Financial Officer at Edwards Lifesciences Corp, with the record behind each one.
Find candidates like Chief Financial Officer at Edwards Lifesciences CorpNew leaders review vendors and budgets in their first months. Get an alert the next time Edwards Lifesciences Corp is in the news or changes leadership.
Get an alert when Edwards Lifesciences Corp changes leadershipTools for this story
Each opens in a new tab, filled in for Edwards Lifesciences Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.